Modulation of signaling cross-talk between pJNK and pAKT generates optimal apoptotic response

Sharmila Biswas1, Baishakhi Tikader2, Sandip Kar2

  • 1Department of Chemical Engineering, Indian Institute of Technology Bombay, Mumbai, India.

Insights

Cancer cells evade apoptosis by altering signaling. This study quantifies synergistic signaling cross-talk between phosphorylated JNK (pJNK) and phosphorylated AKT (pAKT) to optimize tumor necrosis factor alpha (TNFα)-mediated cell death.

Area of Science:

  • Cellular biology
  • Systems biology
  • Cancer research

Background:

  • Tumor necrosis factor alpha (TNFα) regulates apoptosis in normal cells.
  • Cancer cells often resist TNFα-induced apoptosis via altered signaling.
  • Optimizing TNFα-mediated apoptosis requires understanding signaling cross-talk.

Purpose of the Study:

  • To quantitate synergistic signaling cross-talk between pJNK and pAKT.
  • To understand how this cross-talk modulates apoptosis.
  • To identify potential therapeutic targets for enhancing apoptosis.

Main Methods:

  • Experimental data-driven mathematical modeling.
  • Quantification of synergistic signaling cross-talk.
  • Analysis of activated Caspase3 dynamics.

Main Results:

  • Synergistic signaling between pJNK and pAKT orchestrates apoptosis.
  • Distinct synergistic dynamics occur in early and late phases.
  • Apoptosis levels correlate with simulated Caspase3 transients.
  • Perturbing pJNK and pAKT dynamics fine-tunes apoptosis.

Conclusions:

  • Synergism in signal flow is influenced by TNFα receptor and NFκB pathways.
  • Mathematical modeling provides insights into apoptosis regulation.
  • Targeting pJNK and pAKT dynamics may offer novel cancer therapies.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.9K